Pharmaceutical developer Starpharma (ASX:SPL) has received EU approval for the company’s antiviral nasal spray Viraleze.
Studies have shown that the product is effective in combatting respiratory viral diseases such as COVID-19. Experts believe the spray can hinder the spread of the coronavirus, when used in conjunction with vaccines and public health mechanisms. Starpharma expects to have enough supply for distribution into the European market from next month.
Shares in Starphama (ASX:SPL) are trading 5.45 per cent higher at $2.32
08 Mar 2021 - Global inspection business ALS (ASX:ALQ) today announced the acquisition of Investiga, a pharmaceutical testing business in Brazil and the USA.
29 Aug 2024 - A snapshot of the stocks on the move, featuring Battery Age Minerals (ASX:BM8), HyTerra (ASX:HYT) and Vection Technologies (ASX:VR1, OTC:VCTNY).
02 Sep 2020 - Nufarm (ASX:NUF) expects to recognise non-cash, impairment charges in relation to its European assets of approximately $215 million in financial statements for the year ended 31 July 2020.
14 Jul 2020 - Electronic design software company Altium Limited (ASX:ALU) achieved revenue growth of 10 per cent to US $189 million for the full year ended 30 June 2020 despite the challenging Covid-19 environment.
19 Feb 2021 - Cochlear (ASX:COH) report strong growth in the US, Japan, Korea and China, improving momentum in Western Europe and a slower recovery across most emerging markets.
20 Nov 2019 - Contractor MACA (ASX:MLD) has received a letter of award from First Quantum Minerals for open pit mining services at the Ravensthorpe nickel project in southern Western Australia.
17 Feb 2020 - Atlas Arteria (ASX:ALX) is pleased to announce that anti-trust clearance from the European Commission and foreign investment control clearance from the French Ministry of the Economy have now been obtained.
21 Dec 2022 - A snapshot of the stocks on the move featuring Matrix Composites & Engineering (ASX:MCE), DroneShield (ASX:DRO) and MedAdvisor (ASX:MDR).
